APA
Toledo-Sherman L. M., Prime M. E., Mrzljak L., Beconi M. G., Beresford A., Brookfield F. A., Brown C. J., Cardaun I., Courtney S. M., Dijkman U., Hamelin-Flegg E., Johnson P. D., Kempf V., Lyons K., Matthews K., Mitchell W. L., O'Connell C., Pena P., Powell K., Rassoulpour A., Reed L., Reindl W., Selvaratnam S., Friley W. W., Weddell D. A., Went N. E., Wheelan P., Winkler C., Winkler D., Wityak J., Yarnold C. J., Yates D., Munoz-Sanjuan I. & Dominguez C. (20150414). Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease. : Journal of medicinal chemistry.
Chicago
Toledo-Sherman Leticia M, Prime Michael E, Mrzljak Ladislav, Beconi Maria G, Beresford Alan, Brookfield Frederick A, Brown Christopher J, Cardaun Isabell, Courtney Stephen M, Dijkman Ulrike, Hamelin-Flegg Estelle, Johnson Peter D, Kempf Valerie, Lyons Kathy, Matthews Kimberly, Mitchell William L, O'Connell Catherine, Pena Paula, Powell Kendall, Rassoulpour Arash, Reed Laura, Reindl Wolfgang, Selvaratnam Suganathan, Friley Weslyn Ward, Weddell Derek A, Went Naomi E, Wheelan Patricia, Winkler Christin, Winkler Dirk, Wityak John, Yarnold Christopher J, Yates Dawn, Munoz-Sanjuan Ignacio and Dominguez Celia. 20150414. Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease. : Journal of medicinal chemistry.
Harvard
Toledo-Sherman L. M., Prime M. E., Mrzljak L., Beconi M. G., Beresford A., Brookfield F. A., Brown C. J., Cardaun I., Courtney S. M., Dijkman U., Hamelin-Flegg E., Johnson P. D., Kempf V., Lyons K., Matthews K., Mitchell W. L., O'Connell C., Pena P., Powell K., Rassoulpour A., Reed L., Reindl W., Selvaratnam S., Friley W. W., Weddell D. A., Went N. E., Wheelan P., Winkler C., Winkler D., Wityak J., Yarnold C. J., Yates D., Munoz-Sanjuan I. and Dominguez C. (20150414). Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease. : Journal of medicinal chemistry.
MLA
Toledo-Sherman Leticia M, Prime Michael E, Mrzljak Ladislav, Beconi Maria G, Beresford Alan, Brookfield Frederick A, Brown Christopher J, Cardaun Isabell, Courtney Stephen M, Dijkman Ulrike, Hamelin-Flegg Estelle, Johnson Peter D, Kempf Valerie, Lyons Kathy, Matthews Kimberly, Mitchell William L, O'Connell Catherine, Pena Paula, Powell Kendall, Rassoulpour Arash, Reed Laura, Reindl Wolfgang, Selvaratnam Suganathan, Friley Weslyn Ward, Weddell Derek A, Went Naomi E, Wheelan Patricia, Winkler Christin, Winkler Dirk, Wityak John, Yarnold Christopher J, Yates Dawn, Munoz-Sanjuan Ignacio and Dominguez Celia. Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease. : Journal of medicinal chemistry. 20150414.